HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazole

structure given in first source; inhibits p38 MAP kinase
Also Known As:
SB 202190; SB-202190; SB202190; phenol, 4-(4-(4-fluorophenyl)-5-(4-pyridinyl)-1h-imidazol-2-yl)-
Networked: 89 relevant articles (3 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Zhang, Guohua: 4 articles (01/2021 - 07/2013)
2. Sin, Thomas K: 3 articles (01/2021 - 10/2018)
3. Ryter, Stefan W: 2 articles (01/2022 - 08/2008)
4. Li, Yi-Ping: 2 articles (01/2021 - 07/2013)
5. Bao, Huiqiong: 2 articles (01/2020 - 10/2018)
6. Chen, Jyh-Yih: 2 articles (01/2020 - 02/2019)
7. Su, Bor-Chyuan: 2 articles (01/2020 - 02/2019)
8. Kang, Tae-Cheon: 2 articles (11/2016 - 09/2015)
9. Simone, Cristiano: 2 articles (12/2012 - 09/2007)
10. Brunetti, Jesús Emanuel: 1 article (03/2022)

Related Diseases

1. Memory Disorders (Memory Loss)
2. Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
3. Sunburn
4. Chondrosarcoma
5. Infections

Related Drugs and Biologics

1. p38 Mitogen-Activated Protein Kinases
2. Phosphotransferases (Kinase)
3. Proteins (Proteins, Gene)
4. Mitogens
5. 2- (4- nitrophenyl)- 4- (4- fluorophenyl)- 5- (4- pyridinyl)- 1H- imidazole
6. 2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- one
7. SB 203580
8. Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
9. Mitogen-Activated Protein Kinases
10. Interleukin-6 (Interleukin 6)

Related Therapies and Procedures

1. Filtering Surgery
2. Ligation
3. Debridement
4. Keratectomy